- Home
- SRPT vs WGSWW Comparison
SRPT vs WGSWW Comparison
Compare SRPT & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- WGSWW
- Stock Information
- Founded
- SRPT 1980
- WGSWW 2017
- Country
- SRPT United States
- WGSWW United States
- Employees
- SRPT N/A
- WGSWW 1000
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- SRPT Health Care
- WGSWW Technology
- Exchange
- SRPT Nasdaq
- WGSWW Nasdaq
- Market Cap
- SRPT N/A
- WGSWW N/A
- IPO Year
- SRPT 1997
- WGSWW N/A
- Fundamental
- Price
- SRPT $20.28
- WGSWW $0.03
- Analyst Decision
- SRPT Buy
- WGSWW
- Analyst Count
- SRPT 26
- WGSWW 0
- Target Price
- SRPT $70.92
- WGSWW N/A
- AVG Volume (30 Days)
- SRPT 6.5M
- WGSWW 36.6K
- Earning Date
- SRPT 08-06-2025
- WGSWW 02-18-2025
- Dividend Yield
- SRPT N/A
- WGSWW N/A
- EPS Growth
- SRPT N/A
- WGSWW N/A
- EPS
- SRPT N/A
- WGSWW N/A
- Revenue
- SRPT $2,233,371,000.00
- WGSWW $305,450,000.00
- Revenue This Year
- SRPT $26.87
- WGSWW N/A
- Revenue Next Year
- SRPT $3.15
- WGSWW N/A
- P/E Ratio
- SRPT N/A
- WGSWW N/A
- Revenue Growth
- SRPT 59.15
- WGSWW 50.79
- 52 Week Low
- SRPT $18.30
- WGSWW $0.17
- 52 Week High
- SRPT $173.25
- WGSWW $0.21
- Technical
- Relative Strength Index (RSI)
- SRPT 20.82
- WGSWW N/A
- Support Level
- SRPT $18.30
- WGSWW N/A
- Resistance Level
- SRPT $22.98
- WGSWW N/A
- Average True Range (ATR)
- SRPT 2.20
- WGSWW 0.00
- MACD
- SRPT -1.46
- WGSWW 0.00
- Stochastic Oscillator
- SRPT 8.90
- WGSWW 0.00
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.